Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

2.1K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2.1K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

8.5K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
8.5K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Damage-induced i-loops generate eccDNA from repetitive elements.

Molecular cellยท2026
Same author

Effects of Rheopheresis in dialysis patients with peripheral artery disease and diabetic foot ulcers: A multicentric Italian study.

Journal of clinical apheresisยท2024
Same author

Correction to: Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.

Journal of nephrologyยท2024
Same author

[Calcified Fibrin Sheath After Stuck Catheter Removal: Case Report and Literature Review].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologiaยท2024
Same author

Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer.

Cell death & diseaseยท2024
Same author

SnapShot: Tolerating replication stress.

Molecular cellยท2024

Related Experiment Video

Updated: May 1, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.0K

[Hemoperitoneum after drop-out from peritoneal dialysis].

Giuseppe Gernone, Vito Pepe, Michele Giannattasio

    Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
    |March 28, 2014
    PubMed
    Summary

    Encapsulating peritoneal sclerosis is a rare complication of peritoneal dialysis. Early recognition and immunosuppressive treatment can lead to favorable outcomes in patients with end-stage renal disease.

    More Related Videos

    Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
    06:23

    Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

    Published on: May 23, 2025

    3.1K
    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
    06:27

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

    Published on: July 20, 2022

    2.9K

    Related Experiment Videos

    Last Updated: May 1, 2026

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    15.0K
    Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
    06:23

    Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

    Published on: May 23, 2025

    3.1K
    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
    06:27

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

    Published on: July 20, 2022

    2.9K

    Area of Science:

    • Nephrology
    • Gastroenterology
    • Pathology

    Background:

    • Peritoneal dialysis (PD) is a common treatment for end-stage renal disease (ESRD).
    • Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of long-term PD.
    • EPS can lead to ultrafiltration failure and other complications, necessitating transfer to hemodialysis.

    Observation:

    • A 55-year-old woman with ESRD developed bloody ascites after transitioning from PD to hemodialysis.
    • She had a history of exit-site infections and culture-negative peritonitis during 8 years of PD.
    • Clinical and radiological findings suggested EPS, confirmed by peritoneal biopsy.

    Findings:

    • The patient presented with symptoms suggestive of encapsulating peritoneal sclerosis.
    • Peritoneal biopsy confirmed the diagnosis of EPS.
    • Treatment with immunosuppressive therapy resulted in a successful clinical outcome.

    Implications:

    • This case highlights the importance of recognizing the clinical features of EPS in PD patients.
    • Early diagnosis and appropriate treatment, including immunosuppression, are crucial for managing EPS.
    • Despite its rarity and severity, favorable outcomes are possible with timely intervention.